Comments for: FDA halts distribution of Paxil CR, Avandamet

WASHINGTON – The Food and Drug Administration halted distribution Friday of the popular anti-depressant Paxil CR and the diabetes drug Avandamet, citing concerns about manufacturing problems. FDA officials said the medications – made by the British pharmaceutical company Glaxo-SmithKline Inc. – showed signs of failing… Read More
Read more
By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.